CME: Offering mifepristone as an abortion option

Article

While family planning clinics are hailing the FDA's recent approval of mifepristone (RU-486) as a noninvasive way to terminate an unwanted pregnancy, ob/gyns who decide to administer the drug need to familiarize themselves with the research on its advantages and disadvantages.

Related Videos
Addressing racial and ethnic disparities in brachial plexus birth Injury | Image Credit: shrinerschildrens.org
The importance of nipocalimab’s FTD against FNAIT | Image Credit:  linkedin.com
Unveiling gender disparities in medicine | Image Credit:  findcare.ahn.org.
Clinical pearls of pediatric dermatology | Image Credit: profiles.ucsf.edu
Managing skin health in women | Image Credit: profiles.ucsf.edu.
The importance of maternal vaccination | Image Credit: nfid.org.
John Stanley, MD
Sean Esplin, MD
Related Content
© 2024 MJH Life Sciences

All rights reserved.